InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,452.08
(
0.46%
)
US TECH 100
18,536.40
(
0.01%
)
Dow Jones
40,183.20
(
0.83%
)
Brent Oil
81.07
(
0.41%
)
Bitcoin
64,712.70
(
-1.01%
)
Post# of 252672
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

JohnWayne

Send PM Follow Ignore
Followers 6
Posts 271
Boards Moderated 0
Alias Born 12/22/2011

JohnWayne

Re: DewDiligence post# 218339

Friday, 04/06/2018 10:13:05 AM

Friday, April 06, 2018 10:13:05 AM

Post# of 252672
Wow! That’s bad. Wonder what will happen with all the other ongoing Phase 3s that just started. I think melanoma is the only one that compares head to head against PD-1 monotherapy, but the other trials have fairly active comparators that you wouldn’t expect monotherapy to beat...

Looks like door for the next IO doublet might still be wide open. Good news for NKTR!
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up